Methotrexate vs Nivolumab
Methotrexate vs Nivolumab: Overview
This comparison examines the pharmacological differences between Methotrexate and Nivolumab.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Methotrexate — 3-10 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Methotrexate — C20H22N8O5.
Molecular Weight: Methotrexate — 454.4400 g/mol.
Type: Methotrexate — Small molecule; Nivolumab — Antibody.